An erectile dysfunction drug and an antidepressant were inadvertently packaged together during bottling, according to a drug recall warning.
WASHINGTON – Pharmaceutical company AvKare announced the voluntary recall of two lots of 100 mg tablets because a drug used to treat erectile dysfunction was mistakenly packaged with an antidepressant.
A “product mix” of sildenafil and trazodone caused the drugs to “inadvertently pack the drugs together when bottling at a third-party facility,” the company said in a recall notice.
Sildenafil, the active ingredient in Viagra, is used for the treatment of erectile dysfunction. Trazodone is used to treat ‘major depressive disorder’, according to the recall notice.
The company warned that unintentionally taking trazodone can have adverse health consequences such as sedation, dizziness, constipation, and blurred vision.
Unintentional consumption of sildenafil can pose serious health risks to people with underlying medical conditions, such as lowering blood pressure to levels dangerous for those who take prescriptions containing nitrates.
The recalled bottles of trazodone hydrochloride are 1000 unit bottles of lot 36783 with an expiration date of June 2022, NDC # 42291-834-10.
The recalled sildenafil vials are 100-unit vials of lot 36884 with an expiration date of March 2022 and NDC # 42291-748-01.
AvKare said the products are being distributed nationwide by its distributors and wholesalers.
Consumers with questions regarding the recall can contact AvKARE at 1-855-361-3993 Monday through Friday (9 a.m. to 5 p.m. EST).
RELATED: FDA: Romaine Sold in 15 States Voluntarily Recalled Due to E. coli Risk
RELATED: 2 Types of Cottonelle Disposable Wipes Recalled for Bacterial Contamination
RELATED: Diabetes Drug Recall Because It May Contain High Levels Of Carcinogenic Compound